Profile
Christophe Maréchal currently works at Neuralis SA, as Co-Managing Director and Hyloris Pharmaceuticals SA, as Chief Financial Officer from 2024.
Mr. Maréchal also formerly worked at Mithra Pharmaceuticals SA, as Co-Chief Executive Officer in 2024 and Hamon & Cie (International) SA, as Director-Group Treasury & Credit Risk Management.
Mr. Maréchal received his undergraduate degree from the University of Tilburg and Masters Business Admin degree from the University of Liege.
Christophe Maréchal active positions
| Companies | Position | Start |
|---|---|---|
| HYLORIS PHARMACEUTICALS SA | Director of Finance/CFO | 09/12/2024 |
Neuralis SA
Neuralis SA Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Chief Executive Officer | - |
Former positions of Christophe Maréchal
| Companies | Position | End |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Chief Executive Officer | 01/06/2024 |
| HAMON & CIE (INTERNATIONAL) S.A. | Treasurer | - |
Training of Christophe Maréchal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Hamon & Cie (International) SA
Hamon & Cie (International) SA Industrial MachineryProducer Manufacturing Manufactures and installs cooling products | Producer Manufacturing |
Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for woman health sector | Health Technology |
University of Tilburg
University of Tilburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Liege
University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
Neuralis SA
Neuralis SA Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
- Stock Market
- Insiders
- Christophe Maréchal
















